Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
Saved in:
| Published in: | Cancer and Clinical Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
- Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
- Potential therapeutic targeting of BKCa channels in glioblastoma treatment
- Vitamin D should be considered as a targeted therapy in glioblastoma cases
- NKCC1: A key regulator of glioblastoma progression
- The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
- Oncolytic virus and PD-1/PD-L1 blockade combination therapy